Among the current 18 members of the WFDC family, the most studied elafin (WFDC14) and secretory leukocyte peptidase inhibitor (SLPI) have been reported to be highly expressed in psoriasis lesions (20–22). This evidence concerns the gene SLPI and psoriasis.